Background and Purpose-Cerebral infarctions complicate a variable proportion of tuberculous meningitis (TBM) cases and adversely affect outcomes. The objective of this study was to evaluate the predictors of cerebral infarcts in patients with TBM and to assess their impact on mortality. Methods-The study was based on a retrospective chart review of all patients with TBM admitted to a tertiary care hospital between 2002 and 2013. Data were collected on basic demographics, conventional vascular risk factors, radiological findings, severity of TBM, and neurological outcomes. Data were analyzed using SPSS version 19.0. Binary logistic regression was done to determine the factors predictive of cerebral infarcts and of mortality in patients with TBM. Results-A total of 559 patients were admitted with TBM during the study period. Mean age was 41.9 years (SD, 17.7 years), and 47% were women. A quarter of the patients had stage III disease. One hundred forty-four (25.8%) patients had cerebral infarcts on brain imaging of which 3 quarters were acute or subacute. Those with cerebral infarcts were more likely to be >40 years of age (adjusted odds ratio [AOR], 1.7; 95% CI, 1.1-2.7) and to have hypertension (AOR, 1.8; 95% CI, 1.1-2.8), dyslipidemia (AOR, 9.7; 95% CI, 3.8-24.8), and diabetes mellitus (AOR, 2.2; 95% CI, 1.3-3.6). Presence of cerebral infarction was an independent predictor of mortality among patients with TBM (AOR, 2.1; 95% CI, 1.22-3.5). Conclusions-Cerebral infarcts complicate a substantial proportion of TBM cases. Conventional vascular risk factors are the most important predictors of infarction, and future efforts need to focus on these high-risk patients with TBM to reduce morbidity and mortality.
T uberculosis is a major contributor to global morbidity and mortality and now ranks above HIV in this respect. 1 There were ≈10.4 million incident cases of tuberculosis worldwide in 2016 and ≈1.7 million tuberculosis deaths. 2 Although there has been a decline in the burden related over the years, South East Asia continues to harbor almost half of all tuberculosis cases even today. Pakistan ranks fifth highest in its tuberculosis burden and accounts for 5% of all global tuberculosis cases.
Tuberculous meningitis (TBM) is one of the most severe forms of extrapulmonary tuberculosis. Because of the difficulty in diagnosis and under-reporting, the true burden of TBM is not known; however, it is estimated to correlate with the prevalence of tuberculosis overall. 3 Cerebral infarctions are a common complication observed in these patients, with estimates ranging between 6% and 47% 4 of all TBM cases. Occurrence of infarction is one of the main predictors for permanent disability in these patients. 5 In our recent review of 404 TBM cases, we reported a poor outcome associated with presence of cerebral infarction on imaging. 6 The mechanisms of infarction in patients with TBM, however, are not well understood. Several varying pathogeneses are suggested for them including but not limited to vasculitis, arterial thrombosis, and vascular proliferation. 7 As a result, despite infarctions being an important predictor of outcome in TBM, no effective therapeutic strategy is agreed on for their prevention. Both corticosteroids and acetyl salicylic acid have been evaluated, and to date neither has been shown to be an effective preventive therapy 8, 9 against infarctions. The objective of our study was to evaluate the predictors of cerebral infarction in patients with TBM to better understand potential mechanism of stroke in these patients. A second objective was to evaluate the impact of these infarcts on the morbidity and mortality of patients with TBM in this larger sample. Identification of potential mechanisms may be helpful to determination of potential treatment options.
Methods
All data can be made available from the corresponding author on request.
Study Design and Subjects
The study was an analytic cross-sectional study, based on retrospective chart review. All subjects admitted to the Aga Khan University hospital, Karachi, Pakistan, during a period of 12 years (2002-2013) with a diagnosis of TBM were included. The following search terms and International Classification of Diseases codes were used to identify cases from the medical records: (tuberculosis meningitis), 01320 to 01326 (tuberculosis brain), 01330 to 01336 (tuberculous abscess of brain), 01380 to 01386 (other specified tuberculosis of central nervous system), and 01390 to 01396 (unspecified tuberculosis of central nervous system). Once these cases were identified, detailed chart review was performed to collect information. The diagnostic criteria for central nervous system tuberculosis that was used has already been highlighted in an earlier publication. 6 Briefly, we included patients if they had cerebrospinal fluid stain or culture positive for tuberculosis, or biopsy of the lesion showed the organism or caseation and granuloma, or if they had biopsy or culture proven extracranial tuberculosis with abnormal cerebrospinal fluid and enhancing brain lesions on imaging, or if they had abnormal cerebrospinal fluid or brain lesions that responded to antituberculosis treatment (ATT).
Study Variables and Definitions
Data were collected on the following variables:
• Basic demographics-age, sex • Vascular risk factors:
• Hypertension: defined as blood pressure >140 systolic and 90 diastolic on repeated measurements during hospitalization or if the patient was receiving antihypertensive medication at the time of hospital admission.
• Diabetes mellitus: self-reported history, or fasting glucose level of ≥120 mg/dL, or if the patient was receiving oral hypoglycemic agents or insulin on admission.
• Dyslipidemia: fasting serum total cholesterol of ≥200 mg/ dL, and a serum low-density lipoproteins of ≥100 mg/dL, and a serum high-density lipoproteins of ≤40 mg/dL, or if the patient was receiving lipid-lowering drugs at admission.
• Smoking: smoking was considered a risk factor if the patient had smoked ≥10 cigarettes daily for >10 years.
• HIV status of the patient • Infarction was defined as an area of hypodensity in ≥1 arterial territory on a noncontrast head computerized tomography (CT). On magnetic resonance imaging (MRI), infarctions were defined as abnormal signal intensity areas in ≥1 vascular territories, without mass effect. They had to be hypointense on T1-weighted images and hyperintense on T2-weighted as well as fluid attenuated inversion recovery (FLAIR) sequences. 10 All scans were read by a radiologist with expertise in neuroradiology.
• Severity of TBM at presentation was measured according to the Modified British Research Council clinical criteria for TBM severity.
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• Neurological disability was measured using modified Rankin Scale 12 at admission and at discharge.
Data Analysis
Data were analyzed using SPSS version 19. Descriptive statistics are reported as medians with interquartile ranges for quantitative variables and as frequencies for categorical variables. Univariate logistic regression was used to assess the association between presence of infarction and various risk factors, including severity of TBM. Variables with a P<0.2 in univariate analysis were included for multivariate logistic regression. Stepwise logistic regression was then performed to determine variables that were independently related to presence of infarction in patients with TBM. Similar analysis was done to determine the predictors of mortality in patients with infarcts. In addition, survival analysis was performed using log-rank test. P<0.05 was considered significant. All patients admitted at Aga Khan University sign a consent that their data could be used for research. This study was approved by ethical review committee of Aga Khan University.
Results
A total of 559 patients were admitted to our hospital with the diagnosis of TBM between January 2002 and December 2013. The mean age of these patients was 41.9 years (SD, 17.7 years), and 47% were women. Only 49 patients underwent testing for HIV, and only 1 came back positive.
Distribution according to TBM grading was almost equal for grades I and II (212, 37.9% and 211, 37.7%) respectively. There were 136 (24.3%) participants in grade III. Tuberculomas were present in 206 (36.9%) patients. Two hundred fourteen patients (38.3%) had motor deficits at presentation ( Table 1 ).
All patients received 4 drug regimen (ATT) including rifampicin, isoniazid, ethambutol, and pyrazinamide in standard doses for 3 to 4 months and then received 3 drug ATT (excluding ethambutol or pyrizinamide) for 9 to 12 months. ATT was partially or fully discontinued in 34 patients, largely because of hepatotoxicity. More than 90% patients received ATT for 1 year. Streptomycin was used in 44 patients in combination with other ATT.
Radiological Features
All 559 patients underwent neuroimaging. Trained neuroradiologists reviewed 661 first scans (CT=209; MRI=452), 105 second scans (CT=52; MRI=53), and 21 third scans (CT=14; MRI=7). Magnetic resonance angiogram and magnetic resonance venogram were done in only 67 patients. None of the patients had CT angiogram or cerebral angiogram.
One hundred forty-four patients (25.8%) had cerebral infarctions on brain imaging. One hundred five patients had acute or subacute infarctions, meaning that they had developed while their TBM was active. The rest had chronic infarctions. Twenty-five of the 105 patients did not have infarcts on initial CT or MRI but developed them on follow-up scans. 
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Of the 144 patients with infarctions, more than half had multiple infarcts on imaging. Eighty percent of the lesions were located in supratentorial region. A majority of the infarcts were located in subcortical white matter, with around one-fifth of them located in basal ganglia/thalamus and brain stem/cerebellum, respectively. Only 12.9% of the infarcts were located in lobar region. Tuberculomas, hydrocephalus, and basal enhancement were other common findings in patients with infarction ( Table 2) .
Predictors of Cerebral Infarction
We compared the characteristics of the 144 patients with infarcts on neuroimaging with those of 415 without infarcts. Those with infarcts were significantly older (50 versus 35 years) and were significantly more likely to have conventional risk factors like diabetes mellitus, hypertension, and dyslipidemia. Five hundred twelve patients (91% of total TBM cases) received steroids for a period of 4 to 6 weeks.
Multivariable logistic regression showed age >40 years, hypertension (adjusted odds ratio [AOR]=1.7; 95% CI, 1.1-2.8), dyslipidemia (AOR=9.7; 95% CI, 3.8-24.8), and diabetes mellitus (AOR=2.2; 95% CI, 1.3-3.6), to be independent predictors of infarcts when controlling for other variables (Table 3) . A large proportion of patients (58%) with cerebral infarcts had active pulmonary tuberculosis; however, this did not come out significant when adjusting for all other factors. In addition, the use of steroids had no effect on the development of cerebral infarctions.
Predictors of Mortality
Of 559 patients, seventy-seven (13.8%) died during hospital stay. Of these, 35 patients (45% of all who died) had stroke on neuroimaging. Presence of cerebral infarction was an independent predictor of mortality among patients with TBM (AOR, 2.1; 95% CI, 1.22-3.5).
Diabetes mellitus and presence of tuberculoma were independent predictors of mortality among patients with cerebral infarcts. None of the radiological characteristics, including infarct location, basilar enhancement, and hydrocephalus, were associated with mortality among patients with infarcts (Table 4) .
We also performed survival analysis using log-rank test but found no significant difference between the survival times of patients with and without infarction (Figure) .
Discussion
In our study of 559 TBM cases, we have demonstrated that cerebral infarcts were present in 26% of these patients. The commonest sites affected are subcortical white matter followed by basal ganglia and thalamus. Major predictors for infarcts in our patients were the classical risk factors of age, hypertension, diabetes mellitus, and dyslipidemia. Controlling for other predictors, infarcts were independently related with poor outcomes in terms of functional disability and death. Tuberculoma and diabetes mellitus were also major predictors for mortality in patients with infarcts.
Several mechanisms for development of infarction have been proposed in patients experiencing TBM. Basal exudates are considered to be the main culprits for ischemia. 13 These inflammatory exudates lead to vasculitis, thrombosis, as well as vasospasm and strangulation of blood vessels that are passing through the base of skull.
14 There is some evidence to support the view that stroke that occur early on in the course of the disease is secondary to vasospasm and vasculitis, whereas those seen later tend to be a result of intimal proliferation. 15 Yet another suggested mechanism is a prothrombotic state seen more with stage III meningitis 16 and for which acetyl salicylic acid has been evaluated as a potential preventive therapy. 9 Certain areas of the brain also have a predilection for development of infarctions. These areas referred to as tuberculosis zones include basal ganglia, internal capsule, and thalamus. 17 The exudates of TBM are usually most severe in this area of circle of Willis, and hence this pattern of involvement is seen. However, our findings are different from these previous reports. We found the greatest number of infarctions in the subcortical white matter and only a fifth in the basal ganglia and thalamus. This may be suggestive of another possibly noninflammatory mechanism of ischemia in these cases. 15 One probable hypothesis is that the initial inflammatory vasculitis is followed by a proliferative process in the intima, which leads to stenosis and ischemia. 18 Also less than a fifth of our patients had involvement of brain stem and cerebellum, which is consistent with findings from some other studies. 10 We also looked at the predictors of infarctions in this patient population and found that the classical risk factors, like age, diabetes mellitus, hypertension, and dyslipidemia, were the most important determinants. We failed to find presence of other TBM-related factors, such as presence of basal exudates, hydrocephalus, and presence of tuberculomas, to be accountable for these strokes. This finding is consistent with a study from India where even though univariate analysis suggested other tuberculosis-related factors but in multivariate analysis only age came out significant. 10 Age was found to be the only predictor of stroke in patients with TBM in another study from India. 9 Yet another study that evaluated the predictors of stroke in patients with TBM 13 found significant association between stroke and hypertension, stage of meningitis, presence of hydrocephalus, and exudates. However, in multiple regression analysis, none of these factor came out significant. One reason for this finding may be the small sample size compared with our study. One study used data from 507 cases of TBM to develop a prediction model for unfavorable outcome and found altered consciousness, diabetes mellitus, immunosuppression, neurological deficits, hydrocephalus, and vasculitis as significant predictors. 19 This study did not look at radiologically proven infarction as was the case with our study. In our search, we failed to find other larger studies evaluating predictors of infarcts in TBM cases.
Our study also found that cerebral infarcts in TBM are independent predictors of poor functional outcome and of mortality in these patients, a finding supported by several previous studies. 13, 20, 21 HIV was tested in <10% of the patients, and only one tested positive. This frequency is low but not surprising. Prevalence of HIV is extremely low among patients with tuberculosis in Pakistan. A large population-based study on 12 000 confirmed patients with tuberculosis found only 42 (0.34%) patients who were HIV positive. 22 This may be the reason why HIV status was not evaluated in a large majority of our patients with tuberculosis meningitis.
Therapeutic interventions to reduce complications of TBM including infarctions have included steroids and antiplatelets. The fact that corticosteroids reduce mortality in patients with TBM is now well established. 23 However, whether they reduce the incidence of stroke in these cases has not yet been fully evaluated. Two recent studies, 1 in the pediatric population 24 and 1 in adults, explored adjunctive use of acetyl salicylic acid in patients with TBM. 9 The results of these 2 studies are not conclusive enough to influence current guidelines; however, there was a trend toward fewer strokes with aspirin in the adult population.
The above data on predictors and therapeutics lead us to suggest a more complex mechanism for development of stroke 
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in TBM, of which an important final pathway may be accelerated atherosclerosis. This may follow the initial vasculitis seen with TBM, but later atherosclerotic process, however, may be dependent more on the conventional cardiovascular risk factors. This is supported by findings from our study, where the major predictors both for occurrence of infarcts as well as mortality were cardiovascular risk factors, like diabetes mellitus and hypertension. This would also explain these infarcts being in the subcortical white matter which is a common site for atherosclerotic lacunes.
A recent review of stroke in South Asian population 25 reported the conventional vascular risk factors to be highly prevalent but also commented on infectious causes as an important contributor in the region. Our study suggests a unique overlap between infectious and noninfectious risk factors contributing toward development of infarcts in an individual patient.
Moreover, patients who had infarcts had worse outcomes compared with those without, independent of the grade of tuberculosis. The conventional cardiovascular risk factors were again the more important predictors of mortality in TBM patients with infarcts. This poor outcome has been suggested by other studies as well. 10, 13, 20, 21 Our study carries several limitations. This was a retrospective study, based on chart review, and therefore carries all the limitations of such observational studies. A prospective study would have enabled us to identify the incidence of strokes in TBM and also the stage of the disease in which they are likely to occur. This might have shed more light on the differing mechanisms for stroke proposed at different stages of TBM. Another major limitation is that MRI was not done for all the patients. Different modalities of imaging can affect the sensitivity of diagnosing infarcts, particularly in the brain stem region. 26 Furthermore, CT scans are not reliable in determination of the age of infarction. Also CT angiography was performed in only a few cases, and therefore, we cannot conclusively comment on presence of atherosclerotic narrowing at least in the major vessels. Majority of patients with infarctions did not undergo a basic stroke work up, including carotid ultrasound, echocardiogram, and sometimes even ECG. A workup for hypercoagulable states was not done in any patient.
Although cerebral infarction was reported as an independent predictor of mortality among patients with TBM, it did not seem to affect the survival time in patients with cerebral infarcts compared with those without cerebral infarcts according to Kaplan-Meier analysis. The results of the 2 techniques differ because the technique used in Table 3 (binary logistic regression) used a binary outcome only while Kaplan-Meier technique also used survival time. It is possible that frequency of mortality may be statistically different in the 2 groups (binary logistic regression) while survival time may be nonsignificant (log-rank test).
Despite these limitations, to the best of our knowledge, our study represents the largest data set, to date, of patients with TBM and of stroke in the presence of TBM. Although efforts have been made previously to identify predictors of infarction in patients with TBM, the number of patients was small and that of strokes was even smaller. As a result, none of the risk factors evaluated in those studies reached statistical significance. Our study is also unique because for the first time such extensive data on other risk factors for cerebral infarction have been collected on patients with TBM and shown to have a significant impact not just on the occurrence of infarct but also on the mortality following it. Our study shows that patients with conventional cardiovascular risk factors should be managed aggressively with respect to these risk factors to avoid development of strokes.
Conclusions and Future Directions
Our study shows that cerebral infarctions complicate a quarter of the cases of TBM and lead to poor outcomes. They are more likely to occur in patients with vascular risk factors; however, there is a need to evaluate further the role of TBM itself in causation of these infarcts through age-and sex-matched controlled studies. For now, we recommend aggressive identification and treatment of these risk factors in all patients with TBM. In addition, there is a need to conduct better designed trials where this high-risk population is randomized to evaluate the role of antiplatelets in stroke prevention in patients with TBM. Aspirin has already shown to have some beneficial effects, and other antiplatelets like cilostazol with fewer hemorrhagic complications may show more promise.
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